Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zileuton for COPD Exacerbations
NCT00493974Phase 3Terminated
- Sponsor
- University of Minnesota
- Start
- Mar 2007
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of zileuton extended release in chronic obstructive pulmonary disease (COPD), sponsored by University of Minnesota. Started Mar 2007; status: terminated.
02
Drugs
zileuton extended release
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00493974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00493974.